Abstract:BACKGROUND:Despite recent reforms, distorting funding mechanisms and over-prescribing still maintain severe financial barriers to medicines access in China. Complicated and interrelated problems in the pharmaceutical sector require a common framework to be resolved as fragmented solutions do not work. We present a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and propose policy recommendations for promoting universal access to medicines in China.METHODS:Drawing on multiple sources of information, including a review of published literatures and official national data, field investigations in six provinces and interviews with key opinion leaders, this paper presents a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and proposes policy recommendations for promoting universal access to medicines in China.RESULTS:Public expenditure on medicines has been strictly controlled since the national healthcare reforms of 2009. Yet total pharmaceutical expenditure (TPE) and total health expenditure growth rates continuously outpaced the growth of gross domestic product (GDP). With 2.4% of GDP, TPE now exceeds that of most high income countries. The distorted provider and consumer incentives in the Chinese health system have not fundamentally changed. Price-setting and reimbursement mechanisms do not promote cost-effective use of medicines. Inappropriate price controls and perverse financial incentives are the un-resolved root causes of preference of originator brands for some major diseases and shortages of low-cost and low-consumption medicines. In addition, access to expensive life-saving medicines is yet systematically addressed.CONCLUSIONS:The complicated and interdependent problems interact in a way that leads to significant system problems in China, which create dual challenges that both the developing country and the developed countries are facing. To further promote access to medicines, China should speed up the re-assessment of the quality and efficacy of domestically produced generic medicines; coordinate various reforms of price determination, insurance payments, and procurement policies; address medicine shortages through comprehensive policies and legislation; establish specific mechanisms to achieve sustainable equitable access to expensive essential medicines with health technology assessment as a tool to ensure that policy and priority setting are created in a coherent and evidence-based way.

Problems and Reform Strategies of Medicines Distribution System in China

Present Situation and Thinking of Pharmaceutical Distribution System in China

A Review of Promoting Access to Medicines in China - Problems and Recommendations.

Analysis on Supply-side Structural Reform Strategy of Drug Distribution Based on Structure-conduct-per-formance Analysis Paradigm

Essential medicines system reform in China:Achievements and challenges

Study On Development And Countermeasure Of Medical Circulation Industry In China Under New Healthcare Reform Background

Reform of Medical Distribution and Circulation in China: Problems and Prospect

Reform of the Essential Drugs Supply Mode in One District,shanghai

Zero mark-up policy of essential medicines system in China:Problems and recommendations

Strategies and policy recommendations on improving essential medicines system in China

The Existing Problems and Countermeasures of Implementing the Essential Drugs System

Drug policy in China. Transformations, current status and future prospects

Investigation on the Issues about Distribution of National Essential Drug

Investigation on the Influence of Current Status of Logistics Distribution System to the Accessibility of Essential Medicines

The study of the drug distribution system in China under the "two-receipt" drug purchasing policy: A case of Fujian and Shaanxi Province

The Current Status and Development Countermeasures of Online Pharmacies in China

A Study on the Electronic Supervision Model of Drug Distribution.

Research on supervision system of prescription drug e-commerce

Investigation on the Difficulties of Implementation of National Essential Drug System

Investigation on"Two Tax Bill"Medicines Distribution Reform

Investigation of the Availability and Accessibility of Essential Drugs Based on Experience Abroad